Evaluation of PD-L1 expression and associated tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma M Vassilakopoulou, M Avgeris, V Velcheti, V Kotoula, T Rampias, ... Clinical Cancer Research 22 (3), 704-713, 2016 | 213 | 2016 |
Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials V Kotoula, K Chatzopoulos, S Lakis, Z Alexopoulou, E Timotheadou, ... Oncotarget 7 (4), 5074, 2016 | 72 | 2016 |
Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors K Chatzopoulos, JM Boland Virchows Archiv 478 (1), 21-30, 2021 | 48 | 2021 |
CD206‐positive myeloid cells bind galectin‐9 and promote a tumor‐supportive microenvironment EAL Enninga, K Chatzopoulos, JT Butterfield, SL Sutor, AA Leontovich, ... The Journal of pathology 245 (4), 468-477, 2018 | 48 | 2018 |
Immunostimulatory bacterial antigen–armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy E Panagioti, C Kurokawa, K Viker, A Ammayappan, SK Anderson, ... The Journal of clinical investigation 131 (13), 2021 | 43 | 2021 |
Tumor infiltrating lymphocytes and CD8+ T cell subsets as prognostic markers in patients with surgically treated laryngeal squamous cell carcinoma K Chatzopoulos, V Kotoula, K Manoussou, K Markou, K Vlachtsis, ... Head and Neck Pathology 14, 689-700, 2020 | 30 | 2020 |
Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density? T Koletsa, V Kotoula, GA Koliou, K Manousou, S Chrisafi, F Zagouri, ... Cancer Immunology, Immunotherapy 69, 1549-1564, 2020 | 28 | 2020 |
Angiogenic and antiangiogenic VEGFA splice variants in colorectal cancer: prospective retrospective cohort study in patients treated with irinotecan-based chemotherapy and … G Pentheroudakis, L Mavroeidis, K Papadopoulou, GA Koliou, C Bamia, ... Clinical Colorectal Cancer 18 (4), e370-e384, 2019 | 27 | 2019 |
Concurrent appendiceal and umbilical endometriosis: a case report and review of the literature D Paramythiotis, G Stavrou, S Panidis, D Panagiotou, K Chatzopoulos, ... Journal of Medical Case Reports 8, 1-5, 2014 | 23 | 2014 |
Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer G Polychronidou, V Kotoula, K Manousou, I Kostopoulos, ... PLoS One 13 (12), e0208221, 2018 | 19 | 2018 |
Increased ERBB2 Gene Copy Numbers Reveal a Subset of Salivary Duct Carcinomas with High Densities of Tumor Infiltrating Lymphocytes and PD-L1 Expression K Chatzopoulos, AR Collins, S Sotiriou, MG Keeney, DW Visscher, ... Head and Neck Pathology 14, 951-965, 2020 | 14 | 2020 |
Clinicopathologic predictors of survival in buccal squamous cell carcinoma LM Marinelli, K Chatzopoulos, JP Marinelli, TY Chen, AR Collins, ... Journal of Oral Pathology & Medicine 49 (9), 857-864, 2020 | 13 | 2020 |
Immunohistochemical expression of carbonic anhydrase 9, glucose transporter 1, and paired box 8 in von Hippel-Lindau disease–related lesions K Chatzopoulos, MC Aubry, S Gupta Human Pathology 123, 93-101, 2022 | 11 | 2022 |
Ceruminous adenoma of the external auditory canal: a case report with imaging and pathologic findings G Psillas, A Krommydas, G Karayannopoulou, K Chatzopoulos, ... Case Reports in Medicine 2015 (1), 359627, 2015 | 11 | 2015 |
Clinical, radiologic, and pathologic characteristics of pulmonary hamartomas with uncommon presentation K Chatzopoulos, TF Johnson, JM Boland American journal of clinical pathology 155 (6), 903-911, 2021 | 10 | 2021 |
Relapsed and de novo metastatic her2-positive breast cancer treated with trastuzumab: Tumor genotypes and clinical measures associated with patient outcome V Kotoula, K Tsakiri, GA Koliou, G Lazaridis, K Papadopoulou, ... Clinical Breast Cancer 19 (2), 113-125. e4, 2019 | 10 | 2019 |
Tumor infiltrating lymphocytes affect the outcome of patients with operable triple-negative breast cancer in combination with mutated amino acid classes V Kotoula, S Lakis, IS Vlachos, E Giannoulatou, F Zagouri, Z Alexopoulou, ... PLoS One 11 (9), e0163138, 2016 | 10 | 2016 |
Transcriptomic and immunophenotypic characterization of tumor immune microenvironment in squamous cell carcinoma of the oral tongue K Chatzopoulos, S Sotiriou, AR Collins, P Kartsidis, AC Schmitt, X Chen, ... Head and Neck Pathology 15, 509-522, 2021 | 9 | 2021 |
T cell fraction impacts oncologic outcomes in human papillomavirus associated oropharyngeal squamous cell carcinoma KM Van Abel, DM Routman, EJ Moore, DJ Ma, LX Yin, PA Fields, ... Oral Oncology 111, 104894, 2020 | 9 | 2020 |
Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended … G Papaxoinis, V Kotoula, E Giannoulatou, GA Koliou, V Karavasilis, ... Medical Oncology 35, 1-13, 2018 | 9 | 2018 |